Senior Director, Gene Therapy Operations (Apheresis)

Beam Therapeutics(22 days ago)

HybridFull TimeDirector$260,000 - $320,000Commercial Patient Operations

About this role

The Senior Director, Gene Therapy Operations (Apheresis) will lead Beam's Gene Therapy Operations within the Commercial Patient Operations organization, building and managing the apheresis team to enable commercial launch readiness for an ex vivo autologous gene therapy. This role defines strategy, oversees treatment center activation and qualification, and partners cross-functionally to ensure patient-centric execution and regulatory compliance. The position is critical for establishing commercial operations and ensuring high-quality patient and product handling across the treatment journey.

View Original Listing

Required Skills

Apheresis
Patient Scheduling
Treatment Onboarding
Training
Qualification
Cell Collection
Drug Handling
Infusion Support
Quality Compliance
Regulatory Knowledge

+5 more

Qualifications

Bachelor's Degree
Advanced Degree Preferred (MBA, RN, MPH)
QIA Certification Preferred

About Beam Therapeutics

beamtx.com

Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.